Development and validation of an artificial intelligence proof-of-concept tool for risk-based quality assessment of generic medicines: a South African case study
IntroductionRegulatory authorities in African countries face persistent challenges in ensuring the timely authorization of quality generic medicines due to limited technical capacity and extensive review timelines. The South African medicines regulator (SAHPRA) piloted a risk-based assessment (RBA) framework to expedit…
